Short answer
Protara Therapeutics, Inc. (TARA) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Exhibit 99.1 furnished under Item 2.02, not deemed filed under Exchange Act Section 18.
Protara Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Exhibit 99.1 furnished under Item 2.02, not deemed filed under Exchange Act Section 18
- Disclosure concerns Protara Therapeutics’ fiscal year 2026 results
- Investors should review Exhibit 99.1 for financial results and management commentary
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Protara Therapeutics, Inc. 8-K filings
Get the next TARA 8-K as it lands
Follow TARA for push alerts, or ask the research agent what this filing means.